2018 World Premiere: a life-changing therapy for SCI patients

Subscription

Target population for Neurogel project

NEUROGEL™ THERAPEUTIC PURPOSE AND TARGET POPULATION

NEUROGEL™ targets patients with acute lesions since it limits the formation of the glial scar, but even more so patients with chronic lesions since the gel permanently replaces the cavity created by the surgical removal of the glial scar which forms within weeks of the injury. 

Additionally, NEUROGEL™'s technological cluster could benefit not only people suffering from paralysis, but people with head trauma, spina-bifida, brain tumors or optical nerve lesions.